wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27022535-06238D69-211D-4282-B15A-AB862E40CAD4
Q27022535-06238D69-211D-4282-B15A-AB862E40CAD4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27022535-06238D69-211D-4282-B15A-AB862E40CAD4
Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic review
P2860
Q27022535-06238D69-211D-4282-B15A-AB862E40CAD4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27022535-06238D69-211D-4282-B15A-AB862E40CAD4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8148d909a03e65e09cf63079e5c00d64227cb399
P2860
Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLC.